Chapter/Section Purchase

1 Study Coverage
1.1 Rare Disease Drug Product Introduction
1.2 Global Rare Disease Drug Outlook 2017 VS 2022 VS 2028
1.2.1 Global Rare Disease Drug Sales in US$ Million for the Year 2017-2028
1.2.2 Global Rare Disease Drug Sales in Volume for the Year 2017-2028
1.3 United States Rare Disease Drug Outlook 2017 VS 2022 VS 2028
1.3.1 United States Rare Disease Drug Sales in US$ Million for the Year 2017-2028
1.3.2 United States Rare Disease Drug Sales in Volume for the Year 2017-2028
1.4 Rare Disease Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Rare Disease Drug in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Rare Disease Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Rare Disease Drug Market Dynamics
1.5.1 Rare Disease Drug Industry Trends
1.5.2 Rare Disease Drug Market Drivers
1.5.3 Rare Disease Drug Market Challenges
1.5.4 Rare Disease Drug Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Rare Disease Drug Market Segment by Type
2.1.1 Above 1?
2.1.2 0.65??1?
2.1.3 Below 0.1?
2.2 Global Rare Disease Drug Market Size by Type
2.2.1 Global Rare Disease Drug Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Rare Disease Drug Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Rare Disease Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Rare Disease Drug Market Size by Type
2.3.1 United States Rare Disease Drug Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Rare Disease Drug Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Rare Disease Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Rare Disease Drug Market Segment by Application
3.1.1 Hospital Pharmacies
3.1.2 Speciality Pharmacies
3.1.3 Retail pharmacies
3.1.4 Others
3.2 Global Rare Disease Drug Market Size by Application
3.2.1 Global Rare Disease Drug Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Rare Disease Drug Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Rare Disease Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Rare Disease Drug Market Size by Application
3.3.1 United States Rare Disease Drug Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Rare Disease Drug Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Rare Disease Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Rare Disease Drug Competitor Landscape by Company
4.1 Global Rare Disease Drug Market Size by Company
4.1.1 Top Global Rare Disease Drug Manufacturers Ranked by Revenue (2021)
4.1.2 Global Rare Disease Drug Revenue by Manufacturer (2017-2022)
4.1.3 Global Rare Disease Drug Sales by Manufacturer (2017-2022)
4.1.4 Global Rare Disease Drug Price by Manufacturer (2017-2022)
4.2 Global Rare Disease Drug Concentration Ratio (CR)
4.2.1 Rare Disease Drug Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Rare Disease Drug in 2021
4.2.3 Global Rare Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Rare Disease Drug Manufacturing Base Distribution, Product Type
4.3.1 Global Rare Disease Drug Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Rare Disease Drug Product Type
4.3.3 Date of International Manufacturers Enter into Rare Disease Drug Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Rare Disease Drug Market Size by Company
4.5.1 Top Rare Disease Drug Players in United States, Ranked by Revenue (2021)
4.5.2 United States Rare Disease Drug Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Rare Disease Drug Sales by Players (2020, 2021 & 2022)
5 Global Rare Disease Drug Market Size by Region
5.1 Global Rare Disease Drug Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Rare Disease Drug Market Size in Volume by Region (2017-2028)
5.2.1 Global Rare Disease Drug Sales in Volume by Region: 2017-2022
5.2.2 Global Rare Disease Drug Sales in Volume Forecast by Region (2023-2028)
5.3 Global Rare Disease Drug Market Size in Value by Region (2017-2028)
5.3.1 Global Rare Disease Drug Sales in Value by Region: 2017-2022
5.3.2 Global Rare Disease Drug Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Rare Disease Drug Market Size YoY Growth 2017-2028
6.1.2 North America Rare Disease Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Rare Disease Drug Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Rare Disease Drug Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Rare Disease Drug Market Size YoY Growth 2017-2028
6.3.2 Europe Rare Disease Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Rare Disease Drug Market Size YoY Growth 2017-2028
6.4.2 Latin America Rare Disease Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Rare Disease Drug Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Rare Disease Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Novartis AG
7.1.1 Novartis AG Corporation Information
7.1.2 Novartis AG Description and Business Overview
7.1.3 Novartis AG Rare Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Novartis AG Rare Disease Drug Products Offered
7.1.5 Novartis AG Recent Development
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company Corporation Information
7.2.2 Bristol-Myers Squibb Company Description and Business Overview
7.2.3 Bristol-Myers Squibb Company Rare Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Bristol-Myers Squibb Company Rare Disease Drug Products Offered
7.2.5 Bristol-Myers Squibb Company Recent Development
7.3 Celgene Corporation
7.3.1 Celgene Corporation Corporation Information
7.3.2 Celgene Corporation Description and Business Overview
7.3.3 Celgene Corporation Rare Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Celgene Corporation Rare Disease Drug Products Offered
7.3.5 Celgene Corporation Recent Development
7.4 F. Hoffmann-La Roche Ltd.
7.4.1 F. Hoffmann-La Roche Ltd. Corporation Information
7.4.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
7.4.3 F. Hoffmann-La Roche Ltd. Rare Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.4.4 F. Hoffmann-La Roche Ltd. Rare Disease Drug Products Offered
7.4.5 F. Hoffmann-La Roche Ltd. Recent Development
7.5 Pfizer, Inc.
7.5.1 Pfizer, Inc. Corporation Information
7.5.2 Pfizer, Inc. Description and Business Overview
7.5.3 Pfizer, Inc. Rare Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Pfizer, Inc. Rare Disease Drug Products Offered
7.5.5 Pfizer, Inc. Recent Development
7.6 Sanofi S.A.
7.6.1 Sanofi S.A. Corporation Information
7.6.2 Sanofi S.A. Description and Business Overview
7.6.3 Sanofi S.A. Rare Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Sanofi S.A. Rare Disease Drug Products Offered
7.6.5 Sanofi S.A. Recent Development
7.7 Alexion Pharmaceuticals, Inc.
7.7.1 Alexion Pharmaceuticals, Inc. Corporation Information
7.7.2 Alexion Pharmaceuticals, Inc. Description and Business Overview
7.7.3 Alexion Pharmaceuticals, Inc. Rare Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Alexion Pharmaceuticals, Inc. Rare Disease Drug Products Offered
7.7.5 Alexion Pharmaceuticals, Inc. Recent Development
7.8 Eli Lilly and Company
7.8.1 Eli Lilly and Company Corporation Information
7.8.2 Eli Lilly and Company Description and Business Overview
7.8.3 Eli Lilly and Company Rare Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Eli Lilly and Company Rare Disease Drug Products Offered
7.8.5 Eli Lilly and Company Recent Development
7.9 Novo Nordisk A/S
7.9.1 Novo Nordisk A/S Corporation Information
7.9.2 Novo Nordisk A/S Description and Business Overview
7.9.3 Novo Nordisk A/S Rare Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Novo Nordisk A/S Rare Disease Drug Products Offered
7.9.5 Novo Nordisk A/S Recent Development
7.10 AstraZeneca
7.10.1 AstraZeneca Corporation Information
7.10.2 AstraZeneca Description and Business Overview
7.10.3 AstraZeneca Rare Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.10.4 AstraZeneca Rare Disease Drug Products Offered
7.10.5 AstraZeneca Recent Development
7.11 Eisai Co., Ltd.
7.11.1 Eisai Co., Ltd. Corporation Information
7.11.2 Eisai Co., Ltd. Description and Business Overview
7.11.3 Eisai Co., Ltd. Rare Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Eisai Co., Ltd. Rare Disease Drug Products Offered
7.11.5 Eisai Co., Ltd. Recent Development
7.12 Daiichi Sankyo Company Limited
7.12.1 Daiichi Sankyo Company Limited Corporation Information
7.12.2 Daiichi Sankyo Company Limited Description and Business Overview
7.12.3 Daiichi Sankyo Company Limited Rare Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Daiichi Sankyo Company Limited Products Offered
7.12.5 Daiichi Sankyo Company Limited Recent Development
7.13 Bayer AG
7.13.1 Bayer AG Corporation Information
7.13.2 Bayer AG Description and Business Overview
7.13.3 Bayer AG Rare Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Bayer AG Products Offered
7.13.5 Bayer AG Recent Development
7.14 GlaxoSmithKline
7.14.1 GlaxoSmithKline Corporation Information
7.14.2 GlaxoSmithKline Description and Business Overview
7.14.3 GlaxoSmithKline Rare Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.14.4 GlaxoSmithKline Products Offered
7.14.5 GlaxoSmithKline Recent Development
7.15 Merck & Co., Inc.
7.15.1 Merck & Co., Inc. Corporation Information
7.15.2 Merck & Co., Inc. Description and Business Overview
7.15.3 Merck & Co., Inc. Rare Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Merck & Co., Inc. Products Offered
7.15.5 Merck & Co., Inc. Recent Development
7.16 Johnson & Johnson
7.16.1 Johnson & Johnson Corporation Information
7.16.2 Johnson & Johnson Description and Business Overview
7.16.3 Johnson & Johnson Rare Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Johnson & Johnson Products Offered
7.16.5 Johnson & Johnson Recent Development
7.17 Biogen, Inc.
7.17.1 Biogen, Inc. Corporation Information
7.17.2 Biogen, Inc. Description and Business Overview
7.17.3 Biogen, Inc. Rare Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Biogen, Inc. Products Offered
7.17.5 Biogen, Inc. Recent Development
7.18 Takeda
7.18.1 Takeda Corporation Information
7.18.2 Takeda Description and Business Overview
7.18.3 Takeda Rare Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.18.4 Takeda Products Offered
7.18.5 Takeda Recent Development
7.19 Amgen, Inc.
7.19.1 Amgen, Inc. Corporation Information
7.19.2 Amgen, Inc. Description and Business Overview
7.19.3 Amgen, Inc. Rare Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.19.4 Amgen, Inc. Products Offered
7.19.5 Amgen, Inc. Recent Development
7.20 Deciphera
7.20.1 Deciphera Corporation Information
7.20.2 Deciphera Description and Business Overview
7.20.3 Deciphera Rare Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.20.4 Deciphera Products Offered
7.20.5 Deciphera Recent Development
7.21 Atara Biotherapeutics
7.21.1 Atara Biotherapeutics Corporation Information
7.21.2 Atara Biotherapeutics Description and Business Overview
7.21.3 Atara Biotherapeutics Rare Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.21.4 Atara Biotherapeutics Products Offered
7.21.5 Atara Biotherapeutics Recent Development
7.22 ProQR
7.22.1 ProQR Corporation Information
7.22.2 ProQR Description and Business Overview
7.22.3 ProQR Rare Disease Drug Sales, Revenue and Gross Margin (2017-2022)
7.22.4 ProQR Products Offered
7.22.5 ProQR Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Rare Disease Drug Industry Chain Analysis
8.2 Rare Disease Drug Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Rare Disease Drug Distributors
8.3 Rare Disease Drug Production Mode & Process
8.4 Rare Disease Drug Sales and Marketing
8.4.1 Rare Disease Drug Sales Channels
8.4.2 Rare Disease Drug Distributors
8.5 Rare Disease Drug Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer